Skip to main content
. 2023 Nov 21;15(23):5502. doi: 10.3390/cancers15235502

Figure 1.

Figure 1

Kaplan–Meier survival curves examining the relationship between the occurrence of immune-related adverse events and progression-free survival or overall survival in (A) all patients, and (B) 12-week landmark and (C) 24-week landmark cohorts. n/r = not reached.